Inhalation of tobramycin in patients with cystic fibrosis: Comparison of two methods

Journal of Physiology and Pharmacology

Volumn 58, Issue SUPPL. 5, 2007, Pages 141-154

  Dopfer, R ^a   Brand, P ^b   Mullinger B ^c   Hunger, T ^b   Haussermann S ^b   Meyer, T ^b   Scheuch, G ^c   Siekmeier, R ^d,e  

^a Nachsorgeklinik Tannheim GmbH   (Germany)

^b Inamed Research GmbH and Co KG   (Germany)

^c Activaero GmbH   (Germany)

^d Federal Institute for Drugs and Medical Devices Bundesinstitut für Arzneimittel und Medizinprodukte   (Germany)

^e NONE   (Germany)

Author keywords

Aerosol; Cystic fibrosis; Inhalation therapy; Tobramycin

Indexed keywords

ANTIBIOTIC AGENT; TOBRAMYCIN;

ADOLESCENT; ADULT; AEROSOL; AGED; ANTHROPOMETRY; ARTICLE; BODY PLETHYSMOGRAPHY; CLINICAL ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG INFECTION; MALE; NEBULIZER; PSEUDOMONAS AERUGINOSA; SPIROMETRY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DRUG ADMINISTRATION SCHEDULE; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; NEBULIZERS AND VAPORIZERS; RESPIRATORY MECHANICS; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 40449099605     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)